Clinical Trial Update: RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody

View source ↗

Summary

Real-world study evaluating liposomal paclitaxel in combination with an anti-HER-2 monoclonal antibody for stage IV breast cancer. The status of the trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• liposomal paclitaxel (liposomal paclitaxel)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Breast Cancer Stage IV | Status: UNKNOWN